These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 22349104)

  • 61. Alpha-1-antitrypsin stimulates fibroblast proliferation and procollagen production and activates classical MAP kinase signalling pathways.
    Dabbagh K; Laurent GJ; Shock A; Leoni P; Papakrivopoulou J; Chambers RC
    J Cell Physiol; 2001 Jan; 186(1):73-81. PubMed ID: 11147816
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Augmentation therapy for alpha-1 antitrypsin deficiency--not enough evidence to support its use yet!
    McCarthy C; Dimitrov BD
    COPD; 2010 Jun; 7(3):234; author reply 235-6. PubMed ID: 20486824
    [No Abstract]   [Full Text] [Related]  

  • 63. Development, validation and use of ELISA for antibodies to human alpha-1 antitrypsin.
    Ye GJ; Oshins RA; Rouhani FN; Brantly ML; Chulay JD
    J Immunol Methods; 2013 Feb; 388(1-2):18-24. PubMed ID: 23195820
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Alpha-1-antitrypsin inhibits human immunodeficiency virus type 1.
    Shapiro L; Pott GB; Ralston AH
    FASEB J; 2001 Jan; 15(1):115-122. PubMed ID: 11149899
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Despite challenges, new treatments abound for AAT deficiency.
    Morrow T
    Manag Care; 2004 Feb; 13(2):48-9. PubMed ID: 15004931
    [No Abstract]   [Full Text] [Related]  

  • 66. Reduction of severe exacerbations and hospitalization-derived costs in alpha-1-antitrypsin-deficient patients treated with alpha-1-antitrypsin augmentation therapy.
    Barros-Tizón JC; Torres ML; Blanco I; Martínez MT;
    Ther Adv Respir Dis; 2012 Apr; 6(2):67-78. PubMed ID: 22354900
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Alpha-1 antitrypsin (AAT) deficiency - what are the treatment options?
    Modrykamien A; Stoller JK
    Expert Opin Pharmacother; 2009 Nov; 10(16):2653-61. PubMed ID: 19827990
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Serum α-1 Antitrypsin (AAT) antagonizes intrinsic apoptosis induction in neutrophils from patients with systemic inflammatory response syndrome.
    Sarabhai T; Peter C; Bär AK; Windolf J; Relja B; Wesselborg S; Wahlers T; Paunel-Görgülü A
    PLoS One; 2017; 12(5):e0177450. PubMed ID: 28493974
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Pregnancy in patients with Alpha 1 Antitrypsin (AAT) deficiency and the role of intravenous AAT therapy. Authors' reply.
    Guarnieri G; Achille A; Lococo S; Vianello A
    Pulmonology; 2022; 28(5):411-412. PubMed ID: 35501281
    [No Abstract]   [Full Text] [Related]  

  • 70. Alpha-1 antitrypsin in autoimmune diseases: Roles and therapeutic prospects.
    Sun R; Xu Z; Zhu C; Chen T; Muñoz LE; Dai L; Zhao Y
    Int Immunopharmacol; 2022 Sep; 110():109001. PubMed ID: 35803133
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Alpha-1 antitrypsin: A novel biomarker and potential therapeutic approach for metabolic diseases.
    Zhang X; Ostrov DA; Tian H
    Clin Chim Acta; 2022 Sep; 534():71-76. PubMed ID: 35810800
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Effects of major human antiprotease alpha-1-antitrypsin on the motility and proliferation of stromal cells from human exfoliated deciduous teeth.
    Aldonyte R; Tunaitis V; Surovas A; Suriakaite K; Jarmalaviciute A; Magnusson KE; Pivoriunas A
    Regen Med; 2010 Jul; 5(4):633-43. PubMed ID: 20632864
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Production and characterization of mono-PEGylated alpha-1 antitrypsin for augmentation therapy.
    Liu X; Vanvarenberg K; Kouassi KGW; Mahri S; Vanbever R
    Int J Pharm; 2022 Jan; 612():121355. PubMed ID: 34883205
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Intravenous alpha1-antitrypsin in a child with deficiency and severe lung disease.
    Griese M; Brüggen H
    Eur Respir J; 2009 Jul; 34(1):278-9. PubMed ID: 19567611
    [No Abstract]   [Full Text] [Related]  

  • 75. A Review of Alpha-1 Antitrypsin Binding Partners for Immune Regulation and Potential Therapeutic Application.
    O'Brien ME; Murray G; Gogoi D; Yusuf A; McCarthy C; Wormald MR; Casey M; Gabillard-Lefort C; McElvaney NG; Reeves EP
    Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269582
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The role and importance of glycosylation of acute phase proteins with focus on alpha-1 antitrypsin in acute and chronic inflammatory conditions.
    McCarthy C; Saldova R; Wormald MR; Rudd PM; McElvaney NG; Reeves EP
    J Proteome Res; 2014 Jul; 13(7):3131-43. PubMed ID: 24892502
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The lipid ties of α1-antitrypsin: Structural and functional aspects.
    Segal L; Lewis EC
    Cell Immunol; 2022 May; 375():104528. PubMed ID: 35468329
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Neutrophil Fates in Bronchiectasis and Alpha-1 Antitrypsin Deficiency.
    Russell DW; Gaggar A; Solomon GM
    Ann Am Thorac Soc; 2016 Apr; 13 Suppl 2(Suppl 2):S123-9. PubMed ID: 27115946
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Anti-cytokines as a Strategy in Alpha-1 Antitrypsin Deficiency.
    McElvaney OF; Murphy MP; Reeves EP; McElvaney NG
    Chronic Obstr Pulm Dis; 2020 Jul; 7(3):203-213. PubMed ID: 32503090
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Augmentation therapy in alpha(1)-antitrypsin deficiency.
    Burdon JG; Brenton S; Ayad M; Knight K
    Chest; 2001 Aug; 120(2):687. PubMed ID: 11502686
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.